Get started
Author

Steven P Gelone

Observed names: Gelone Sp, S GELONE, S. Gelone, S. P. Gelone, S.P. Gelone, STEVEN GELONE, STEVEN P GELONE, STEVEN P. GELONE, Steve Gelone, Steven Gelone, Steven P. Gelone, StevenP. Gelone
OpenAlex ID: A5086958262
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
2014 · Stuart Johnson, Thomas J. Louie, et al. · Clinical Infectious Diseases · 543
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
2019 · Thomas M File, Lisa Goldberg, et al. · Clinical Infectious Diseases · 149
Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus
2007 · Angela Sansone‐Parsons, Gopal Krishna, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 139
Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial
2019 · Elizabeth Alexander, Lisa Goldberg, et al. · JAMA · 117
PDF
Fluoroquinolones
2000 · Judith A. O'Donnell, Steven P. Gelone · Infectious Disease Clinics of North America · 80
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
2019 · Thomas M File, Lisa Goldberg, et al. · Clinical Infectious Diseases · 77
PDF
Difficult‐to‐Treat Trichomoniasis: Results with Paromomycin Cream
1998 · Paul Nyirjesy, Jack D. Sobel, et al. · Clinical Infectious Diseases · 74
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015–2016)
2019 · Susanne Paukner, Steven P. Gelone, et al. · Antimicrobial Agents and Chemotherapy · 63
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States
2021 · Vikas Gupta, Kalvin C Yu, et al. · Open Forum Infectious Diseases · 51
PDF
A Randomized, Double-Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients
2009 · M.D. Pescovitz, R. Bloom, et al. · American Journal of Transplantation · 49
Caspofungin Acetate for Treatment of Invasive Fungal Infections
2003 · Staci A Pacetti, Steven P Gelone · Annals of Pharmacotherapy · 47
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials
2022 · Jessica Howard-Anderson, Toshimitsu Hamasaki, et al. · Clinical Infectious Diseases · 45
PDF
Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: Retrospective analysis of 2016–2017 data from US hospitals
2019 · Ying P. Tabak, Arjun Srinivasan, et al. · Infection Control and Hospital Epidemiology · 41
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015–2016 and Characterization of Resistance Mechanisms
2019 · Rodrigo E. Mendes, Susanne Paukner, et al. · Antimicrobial Agents and Chemotherapy · 36
The newer fluoroquinolones
2004 · Judith A O'Donnell, Steven P Gelone · Infectious Disease Clinics of North America · 34
Paromomycin for nitroimidazole-resistant trichomonosis
1995 · Paul Nyirjesy, M. Velma Weitz, et al. · The Lancet · 32
PDF
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia
2019 · Sujata M Bhavnani, Li Zhang, et al. · Journal of Antimicrobial Chemotherapy · 30
Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing
2019 · Wolfgang W Wicha, William T Prince, et al. · Journal of Antimicrobial Chemotherapy · 29
PDF
Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections
2022 · Susanne Jacobsson, Daniel Golparian, et al. · Frontiers in Pharmacology · 27
Clostridium difficile in the Long-Term Care Setting
2007 · A MAKRIS, S GELONE · Journal of the American Medical Directors Association · 26
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin
2021 · Susanne Paukner, Lisa Goldberg, et al. · Journal of Global Antimicrobial Resistance · 18
PDF
Topical Antibacterials
2015 · Judith A. O'Donnell, Steven P. Gelone, et al. · Elsevier eBooks · 18
US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary—Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea
2024 · Hiwot Hiruy, Shukal Bala, et al. · Clinical Infectious Diseases · 10
PDF
7-Year (2015–21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms
2023 · Susanne Paukner, Rodrigo E Mendes, et al. · Journal of Antimicrobial Chemotherapy · 10
PDF
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis
2021 · Wolfgang W. Wicha, Thomas C. Marbury, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 10
Works count: 86
Citation count: 1,872
H-index: 20
I10-index: 25
Year
Topic
Type